Yuichiro Yano1, Jared P Reis2, Yacob G Tedla3, David C Goff4, David R Jacobs5, Stephen Sidney6, Hongyan Ning3, Kiang Liu3, Philip Greenland3, Donald M Lloyd-Jones3. 1. Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois2Department of Preventive Medicine, The University of Mississippi Medical Center, Jackson. 2. Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland. 3. Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois. 4. Department of Epidemiology, Colorado School of Public Health, Aurora. 5. Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis. 6. Division of Research, Kaiser Permanente of Northern California, Oakland.
Abstract
Importance: Data are sparse regarding which blood pressure (BP) components in young adulthood optimally determine cardiovascular disease (CVD) by middle age. Objectives: To assess which BP components best determine incident CVD events in young adults and determine whether these associations vary by race and age at BP measurement. Design, Setting, and Participants: Using data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, this study assessed the longitudinal race-stratified associations between BP and cardiovascular outcomes. CARDIA is a community-based cohort that recruited black and white individuals (age range, 18-30 years) from March 26, 1985, through June 7, 1986. CARDIA followed up participants for up to 28 years, and 94% of the surviving cohort completed at least 1 telephone interview or examination from August 2009 through August 2014. Exposures: Blood pressures measubred at baseline (Y0) and 15 years later (Y15). Main Outcomes and Measures: Composite CVD events, including coronary heart disease, stroke, heart failure, and other vascular diseases. Results: A total of 4880 participants participated in the study (mean [SD] age, 24.9 [3.6] years at Y0 and 25.0 [3.6] years at Y15; 2223 male [45.6%] at Y0 and 1800 [44.2%] at Y15; 2657 female [54.4%] at Y0 and 2277 [55.8%] at Y0; 2473 black individuals [50.7%] at Y0 and 1994 [48.9%] at Y15; and 2407 white individuals [49.3%] at Y0 and 2083 [51.1%] at Y15). The mean SBP/DBP was 112/69 mm Hg in blacks and 109/68 mm Hg in whites at Y0 and 117/77 mm Hg in blacks and 110/72 mm Hg in whites at Y15. During a 25-year follow-up from Y0, 210 CVD events occurred (twice as many events in blacks [n = 140] compared with whites), of which 131 (87 in blacks) occurred after Y15. With adjustments for covariates, results from Cox proportional hazards models, including SBP and DBP, jointly suggested that, at Y0, SBP (hazard ratio [HR] per 1-SD increase, 1.32; 95% CI, 1.09-1.61) but not DBP (HR, 1.05; 95% CI, 0.88-1.26) was associated with CVD risk in blacks, whereas DBP (HR, 1.74; 95% CI, 1.21-2.50) but not SBP (HR, 0.82; 95% CI, 0.57-1.18) was associated with CVD risk in whites. At Y15, SBP was the strongest indicator of CVD in blacks (HR, 1.64; 95% CI, 1.25-2.16) and whites (HR, 1.67; 95% CI, 1.02-2.69). Conclusions and Relevance: This study questions the classic view that DBP is more able to identify future CVD events than SBP in all individuals younger than 50 years. In young adulthood, SBP in black individuals and DBP in white individuals were the most robust indicators of future CVD. In middle-age, SBP in both races identified risk of incident CVD.
Importance: Data are sparse regarding which blood pressure (BP) components in young adulthood optimally determine cardiovascular disease (CVD) by middle age. Objectives: To assess which BP components best determine incident CVD events in young adults and determine whether these associations vary by race and age at BP measurement. Design, Setting, and Participants: Using data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, this study assessed the longitudinal race-stratified associations between BP and cardiovascular outcomes. CARDIA is a community-based cohort that recruited black and white individuals (age range, 18-30 years) from March 26, 1985, through June 7, 1986. CARDIA followed up participants for up to 28 years, and 94% of the surviving cohort completed at least 1 telephone interview or examination from August 2009 through August 2014. Exposures: Blood pressures measubred at baseline (Y0) and 15 years later (Y15). Main Outcomes and Measures: Composite CVD events, including coronary heart disease, stroke, heart failure, and other vascular diseases. Results: A total of 4880 participants participated in the study (mean [SD] age, 24.9 [3.6] years at Y0 and 25.0 [3.6] years at Y15; 2223 male [45.6%] at Y0 and 1800 [44.2%] at Y15; 2657 female [54.4%] at Y0 and 2277 [55.8%] at Y0; 2473 black individuals [50.7%] at Y0 and 1994 [48.9%] at Y15; and 2407 white individuals [49.3%] at Y0 and 2083 [51.1%] at Y15). The mean SBP/DBP was 112/69 mm Hg in blacks and 109/68 mm Hg in whites at Y0 and 117/77 mm Hg in blacks and 110/72 mm Hg in whites at Y15. During a 25-year follow-up from Y0, 210 CVD events occurred (twice as many events in blacks [n = 140] compared with whites), of which 131 (87 in blacks) occurred after Y15. With adjustments for covariates, results from Cox proportional hazards models, including SBP and DBP, jointly suggested that, at Y0, SBP (hazard ratio [HR] per 1-SD increase, 1.32; 95% CI, 1.09-1.61) but not DBP (HR, 1.05; 95% CI, 0.88-1.26) was associated with CVD risk in blacks, whereas DBP (HR, 1.74; 95% CI, 1.21-2.50) but not SBP (HR, 0.82; 95% CI, 0.57-1.18) was associated with CVD risk in whites. At Y15, SBP was the strongest indicator of CVD in blacks (HR, 1.64; 95% CI, 1.25-2.16) and whites (HR, 1.67; 95% CI, 1.02-2.69). Conclusions and Relevance: This study questions the classic view that DBP is more able to identify future CVD events than SBP in all individuals younger than 50 years. In young adulthood, SBP in black individuals and DBP in white individuals were the most robust indicators of future CVD. In middle-age, SBP in both races identified risk of incident CVD.
Authors: John M Flack; Domenic A Sica; George Bakris; Angela L Brown; Keith C Ferdinand; Richard H Grimm; W Dallas Hall; Wendell E Jones; David S Kountz; Janice P Lea; Samar Nasser; Shawna D Nesbitt; Elijah Saunders; Margaret Scisney-Matlock; Kenneth A Jamerson Journal: Hypertension Date: 2010-10-04 Impact factor: 10.190
Authors: Russell V Luepker; Fred S Apple; Robert H Christenson; Richard S Crow; Stephen P Fortmann; David Goff; Robert J Goldberg; Mary M Hand; Allan S Jaffe; Desmond G Julian; Daniel Levy; Teri Manolio; Shanthi Mendis; George Mensah; Andrzej Pajak; Ronald J Prineas; K Srinath Reddy; Veronique L Roger; Wayne D Rosamond; Eyal Shahar; A Richey Sharrett; Paul Sorlie; Hugh Tunstall-Pedoe Journal: Circulation Date: 2003-11-10 Impact factor: 29.690
Authors: Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel Journal: Circulation Date: 2008-01-22 Impact factor: 29.690
Authors: Carmel M McEniery; John R Cockcroft; Mary J Roman; Stanley S Franklin; Ian B Wilkinson Journal: Eur Heart J Date: 2014-01-23 Impact factor: 29.983
Authors: Yuichiro Yano; Jared P Reis; Laura A Colangelo; Daichi Shimbo; Anthony J Viera; Norrina B Allen; Samuel S Gidding; Adam P Bress; Philip Greenland; Paul Muntner; Donald M Lloyd-Jones Journal: JAMA Date: 2018-11-06 Impact factor: 56.272
Authors: Nilay S Shah; Hongyan Ning; Lucia C Petito; Kiarri N Kershaw; Michael P Bancks; Jared P Reis; Jamal S Rana; Stephen Sidney; David R Jacobs; Catarina I Kiefe; Mercedes R Carnethon; Donald M Lloyd-Jones; Norrina B Allen; Sadiya S Khan Journal: Circulation Date: 2022-05-24 Impact factor: 39.918
Authors: John W McEvoy; Natalie Daya; Faisal Rahman; Ron C Hoogeveen; Roger S Blumenthal; Amil M Shah; Christie M Ballantyne; Josef Coresh; Elizabeth Selvin Journal: JAMA Date: 2020-01-28 Impact factor: 56.272
Authors: Chike C Nwabuo; Duke Appiah; Henrique T Moreira; Henrique D Vasconcellos; Yuichiro Yano; Jared P Reis; Ravi V Shah; Venkatesh L Murthy; Norrina B Allen; Stephen Sidney; Paul Muntner; Cora E Lewis; Donald M Lloyd-Jones; Pamela J Schreiner; Samuel S Gidding; João A C Lima Journal: Eur J Prev Cardiol Date: 2021-10-25 Impact factor: 7.804
Authors: Hongwei Ji; Andy Kim; Joseph E Ebinger; Teemu J Niiranen; Brian L Claggett; C Noel Bairey Merz; Susan Cheng Journal: JAMA Cardiol Date: 2020-03-01 Impact factor: 30.154
Authors: Elaine Ku; Eric Vittinghoff; David R Jacobs; Cora E Lewis; Norrina B Allen; Kirsten Bibbins-Domingo; Michael Shlipak; Holly Kramer; Carmen A Peralta Journal: Am J Kidney Dis Date: 2018-03-03 Impact factor: 11.072